Norges Bank
CABA icon

Norges Bank’s Cabaletta Bio CABA Stock Holding History

Norges Bank’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
+4,112,401
New +$13.5M ﹤0.01% 1258
2020
Q2 		– Sell
-47,100
Closed -$344K – 2080
2020
Q1 		$344K Sell
47,100
-17,900
-28% -$245K ﹤0.01% 2022
2019
Q4 		$908K Buy
+65,000
New +$770K ﹤0.01% 2029

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Norges Bank's CABA Position: Q2 2026 in Review

Norges Bank opened a new position in Cabaletta Bio (CABA) in Q2 2026: 4,112,401 shares worth $12.8M. The stake represents ﹤0.01% of the portfolio and ranks #1258 among its holdings. This is a return to the name: Norges Bank previously reported a position in CABA as recently as Q1 2020.

Norges Bank first reported a position in CABA in Q4 2019 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Norges Bank held 4,112,401 shares of Cabaletta Bio worth $12.8M as of Q2 2026.
  • Cabaletta Bio was a new Norges Bank position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1258 holding.
  • Norges Bank first reported a position in Cabaletta Bio in Q4 2019 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.